Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome [1]

Masamitsu Yanada, Xuelin Huang, Guillermo Garcia-Manero, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, Stefan Faderl, Jean Pierre Issa, Hagop Kantarjian, Elihu Estey

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)555-557
Number of pages3
JournalBritish Journal of Haematology
Volume138
Issue number4
DOIs
StatePublished - Aug 2007

Keywords

  • Acute myeloid leukaemia
  • Haematological improvement
  • Myelodysplastic syndrome
  • Survival
  • Targeted therapy

ASJC Scopus subject areas

  • Hematology

Cite this